Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
401k Retirement Calculator
Mortgage Calculator
Popular
Compound Interest Calculator
Dollar Cost Averaging
New
Student Loan Calculator
Auto Loan Calculator
Personal Finance
News
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
TipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
ARGX
Stock Latest News
Press Releases
argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
4d ago
ARGX
Premium
Market News
Biotech Sector: M&A Fuels Renewed Excitement
6d ago
NVS
XBI
Premium
Company Announcements
Argenx’s VYVGART Shows Promising CIDP Treatment Results
20d ago
6K
ARGX
Premium
The Fly
Argenx presents data from ADHERE trial evaluating Vyvgart Hytrulo
20d ago
ARGX
Premium
Press Releases
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease
20d ago
ARGX
Premium
The Fly
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call
26d ago
ARGX
Premium
The Fly
Immunovant initiated with an Outperform at Oppenheimer
1M ago
ARGX
IMVT
Premium
Company Announcements
Argenx Schedules Annual Shareholders’ Meeting 2024
1M ago
6K
ARGX
Premium
Company Announcements
Argenx Advances Promising Sjogren’s Treatment
1M ago
6K
ARGX
Premium
The Fly
Argenx advances clinical development of efgartigimod
1M ago
ARGX
Premium
Press Releases
argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease
1M ago
ARGX
Premium
Press Releases
argenx Announces Annual General Meeting of Shareholders on May 7, 2024
1M ago
ARGX
Premium
The Fly
Argenx price target raised to $408 from $402 at Scotiabank
1M ago
ARGX
Premium
The Fly
Argenx price target raised to $408 from $402 at Scotiabank
1M ago
ARGX
Premium
Company Announcements
Argenx’s VYVGART Wins Approval in Japan for ITP
1M ago
6K
ARGX
Premium
The Fly
Argenx announces MHLW approval of Vyvgart
1M ago
ARGX
Premium
Press Releases
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
1M ago
ARGX
Premium
The Fly
Rocheâs mixed myasthenia gravis data sending these stocks in opposite directions
2M ago
ARGX
IMVT
Premium
The Fly
Rocheâs mixed myasthenia gravis data sending these stocks in opposite directions
2M ago
ARGX
IMVT
Premium
The Fly
Immunovant rallies after Chugai myasthenia gravis study failure
2M ago
ARGX
IMVT
Premium
The Fly
Argenx rallies after Chugai generalized myasthenia gravis study fails
2M ago
ARGX
Premium
Company Announcements
Argenx Highlights 2023 Achievements and Outlook
2M ago
6K
ARGX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.